Literature DB >> 19196201

Vaccination concepts against Toxoplasma gondii.

João Luis Garcia1.   

Abstract

Toxoplasma gondii is a parasite that infects animals and humans worldwide. Despite the current knowledge of immunology, pathology and genetics related to the parasite, a safe vaccine for prevention of the infection in both humans and animals does not exist. Here, we review some aspects concerning vaccination against T. gondii.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19196201     DOI： 10.1586/14760584.8.2.215

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


  10 in total

1.  Vaccines against Toxoplasma gondii: status, challenges and future directions.

Authors:  Qi Liu; Lachhman Das Singla; Huaiyu Zhou
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

2.  Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.

Authors:  Xiu-Zhen Li; Xiao-Hu Wang; Li-Jun Xia; Ya-Biao Weng; Jorge A Hernandez; Li-Qing Tu; Lu-Tao Li; Shou-Jun Li; Zi-Guo Yuan
Journal:  BMC Infect Dis       Date:  2015-03-04       Impact factor: 3.090

3.  Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis.

Authors:  Li-Tian Yin; Hai-Xia Hao; Hai-Long Wang; Jian-Hong Zhang; Xiao-Li Meng; Guo-Rong Yin
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

4.  Immunogenicity of Multiepitope Vaccine Candidate against Toxoplasma gondii Infection in BALB/c Mice.

Authors:  Khalid Hajissa; Robaiza Zakaria; Rapeah Suppian; Zeehaida Mohamed
Journal:  Iran J Parasitol       Date:  2018 Apr-Jun       Impact factor: 1.012

5.  GRA24-Based DNA Vaccine Prolongs Survival in Mice Challenged With a Virulent Toxoplasma gondii Strain.

Authors:  Bin Zheng; Di Lou; Jianzu Ding; Xunhui Zhuo; Haojie Ding; Qingming Kong; Shaohong Lu
Journal:  Front Immunol       Date:  2019-03-06       Impact factor: 7.561

6.  Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.

Authors:  Min Meng; Shenyi He; Guanghui Zhao; Yang Bai; Huaiyu Zhou; Hua Cong; Gang Lu; Qunli Zhao; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2012-11-26       Impact factor: 3.876

Review 7.  Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine.

Authors:  Masoud Foroutan; Fatemeh Ghaffarifar
Journal:  Clin Exp Vaccine Res       Date:  2018-01-29

Review 8.  A one health approach to vaccines against Toxoplasma gondii.

Authors:  Elisabeth A Innes; Clare Hamilton; Joao L Garcia; Andreas Chryssafidis; David Smith
Journal:  Food Waterborne Parasitol       Date:  2019-04-18

9.  Immune Responses Induced by pVAX/TgERK7 against Toxoplasma gondii Infection in BALB/c Mice.

Authors:  Hai-Ting Guo; Zhong-Yuan Li; Jin-Lei Wang; Zhao-Yu Geng; Xing-Quan Zhu
Journal:  Iran J Parasitol       Date:  2019 Oct-Dec       Impact factor: 1.012

10.  Toxoplasma gondii GRA15 DNA Vaccine with a Liposomal Nanocarrier Composed of an SS-Cleavable and pH-Activated Lipid-like Material Induces Protective Immunity against Toxoplasmosis in Mice.

Authors:  Tanjila Hasan; Ryo Kawanishi; Hidetaka Akita; Yoshifumi Nishikawa
Journal:  Vaccines (Basel)       Date:  2021-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.